СПИСОК ИСПОЛЬЗОВАННЫХ источников

1. Parkin DM, Whelan SL, Ferlay J, Teppo L. Cancer incidence in five continents ∕∕ Lyon: IARC Scientific Publications. - 2002.

2. Parkin DM, Whelan SL, Ferlay J, Teppo L.

3. Ferlay J, Bray F, Pisani P et al, editors. Cancer incidence, mortality and prevalence worldwide. ∕∕ Lyon: IARC Cancer Base Press, Globocan - 2004. № 5, version 2.

4. Hai-Rim Shin, Marie Clem Carlos, Cherian Varghese. Cancer Control in the Asia Pacific Region: Current Status and Concerns ∕∕ Jpn. J. Clin. Oncol. - 2012; 42 (10).-P. 867-881.

5. Jung K.W., Park S., Shin A., et al. Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009 H PLoS One. - 2012; 7 (12). - P. e52457.

6. Jemal A., Bray F., Center M.M., et al. Global Cancer Statistics ∕∕ CA cancer J. din.-2011; 61 (2).-P. 69-90.

7. de Souza DL, Perez MM, Curado MP. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control ∕∕ Cancer Epidemiol. - 2011; 35 (6). - P. 510-514.

8. Wiinsch Filho V. The epidemiology Oflaryngeal cancer in Brazil ∕∕ Sao Paulo Med J. - 2004; 122 (5). - P. 188-194.

9. Saurina C., Saez M., Marcos-Gragera R., et al. Effects of deprivation on the geographical variability of larynx cancer incidence in men, Girona (Spain) 1994-2004 ∕∕ Cancer Epidemiol. - 2010; 34 (2). - P. 109-115.

10. Dykhno Iu.A., Ivanova Iu.D., Kas'ianov V.V., et al. Use of geoinformational systems for epidemiological studying malignant laryngeal neoplasms in Krasnoyarsk ∕∕ Gig Sanit. - 2002; 3. - P. 37-39.

ILCancer incidence and Mortality Worldwide in 2008. Globocan 2008: IARC Cancer Base No.

12. European Network of Cancer Registries. EUROCIM (European Cancer Incidence and Mortality). ∕∕ Lyon: International Agency for Research on Cancer - 1997.

13. Teppo H, Koivunen P, Sipila S, Jokinen K, Hyrynkangas K, Laara E, et al. Decreasing incidence and improved survival of laryngeal cancer in Finland. ∕∕ Acta Oncol - 2001 .Vol. 5, 40. - P. 791.

14. Micheli A, Francisci S, Krogh V, Rossi AG, Crosignani P. Cancer prevalence in Italian cancer registry areas: the Itapreval study. ∕∕ Itapreval Working Group. Tumori - 1999. Vol. 85, 309. - P. 69.

15. Berrino F, Capocaccia R, Esteve J. Survival of cancer patients in Europe. The Eurocare-Il Study. ∕∕ IARC - Lyon: International Agency for Research on Cancer. Scient. Publ. - 1999. No. 151.

16. Esteve J, De Angelis G, Verdecchia A. In: Berrino F, Capocaccia R, Esteve J, Gatta G, Hakulinene T, Micheli A, Sant M, Verdecchia A, editors. Trends in

cancer survival probability over the period 1978-1989, survival of Cancer Patients in Europe. The Eurocare-II Study. ∕∕ IARC - Lyon: International Agency for Research on Cancer. Scient. Publ. - 1999. No. 151.

17. WHO. International Classification of Diseases, IOth Revision. - Geneva ∕∕ World Health Organization - 1989.

18. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. ∕∕ Eurocare Working Group. Eur JCancer- 1998. Vol. 34.-P. 2154-2161.

19. Coleman MP, Babb P, Daniecki P, et al. Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS region. ∕∕ London: The Stationary Office. Studies in Medical and Population Subjects - 1999. No. 61.

20. Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Soderman B, et al. Survival of cancer patients in Finland 1955-1994. ∕∕ Acta Oncol - 1999; Vol.

2EWorld Cancer Research Fund and American Institute for Cancer Research, Food, Nutrition and Prevention of Cancer: a Global Perspective. ∕∕ Washington: American Institute of Cancer Research. - 1997.

22. Tuyns AJ, Esteve J, Raymond L, Berrino F, Benhamou E, Blanchet F, et al. Cancer of the larynx∕hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). ∕∕ Int J Cancer. - 1988. Vol. 41. -P. 483-491.

23.Smith AH, Handley MA, Wood R. Epidemiological evidence indicates asbestos causes laryngeal cancer. H J Occup Med - 1990. N 32. - P. 499-507.

24. Merletti F, Heseltine E, Saracci R, Simonato L, Vainio H, Wilbourn J. Target organs for carcinogenicity of chemicals and industrial exposures in humans: a review of results in the IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. ∕∕ Cancer Res - 1984. N 44. P. - 2244-2250.

25. Rafferty MA, Fenton JE, Jones AS. An overview of the role and inter­relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. ∕∕ Clin Otolaryngol - 2001. N 26. P. - 317-320.

26.Steinberg BM. Role of human papillomaviruses in benign and malignant lesions. In: Hong WK, Weber RS, editors. H Head and Neck Cancer: Basic and Clinical Aspects. Boston, MA: Kluwer Academic Publishers. - 1995. P. - 1- 16.

27.Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. ∕∕ J Natl Cancer Inst - 2000. N 92. P. - 709-720.

28.Sixbey JW, Nedmd JG, Raab-Trauh A, Hwies RA. Detection of Epstein-Barr virus DNA and RNA in human pharyngeal epithelial cells. ∕∕ Engl. J. Med. - 1984. Vol. 310.-P. 1225-1230.

29.Исаева T. M. Динамика антител к вирусу Эпштейна-Барр как дополнительный диагностический и прогностический критерий при

опухолях головы и шеи. // автореф. дис. . канд. мед. наук - Томск, 1990. С. 20.

ЗО.Чойнзонов Е. Л. Рак верхних отделов дыхательного и пищварительного тракта (эпидемиологические и иммунологические аспекты, оценка эффективности лечения). // автореф. дис. . докт. мед. наук - Томск, 1995. С.-46.

31. Гончарова Е. В. Вирус Эпштейна-Барр и рак желудка: поиск и анализ вирусологических и молекулярно-генетических маркеровэкспериментальное исследование). // автореф. дисс.

канд.биол.наук. - Москва, 2001. С. - 24.

32. Гурцевич В. Э., Щербак Л. H., Новикова Е. В. Структурные и функциональные особенности гена BMP-I вируса Эпштейна-Барр у больных недифференцированным раком носоглотки в России. // Вестник РАМН. - 2002. № 1. - С. 53-59.

33. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumours. ∕∕ Lancet. - 1994. Vol. 343. - P. 333-335.

34. Fries KL, Miller WE, Traub NR. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. ∕∕ J. Virol. - 1996. N 70. - P. 8653-8659.

35. Thomas J, Felix DH, Wray D. Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. //Am J Pathol. — 1991.Vol. 139.-P. 1369-1380.

36. Hellquist H, Lundgren J, Olofsson J. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords: a follow-up study. H Clin Otolaryngol - 1982. N 7. P. - 11-27.

37. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. International Classification of Diseases for Oncology, 3rd ed. ∕∕ Geneva: World Health Organization - 2000.

38. Taylor CR, Kledzik G. Immunohistologic techniques in surgical pathology: a spectrum of “new” special stains. ∕∕ Hum Pathol - 1981. N 12. P. - 590-596.

39. Brandsma JL, Steinberg BM, Abramson AL, Winkler B.

40.Saul SH, Kapadia SB. Secondary lymphoma of Waldeyer’s ring: natural history and association with prior extranodal disease. ∕∕ Am J Otolaryngol - 1986. N7. P.-34-41.

4LBarbera L, Groome PA, Mackillop WJ, Schulze K, O’Sullivan B, Irish JC, et al. The role of computed tomography in the T classification of laryngeal carcinoma. ∕∕ Cancer - 2001. N 91. P. - 394-407.

42. Kim HJ, Boyd J, Dunphy F, Lowe V. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer. ∕∕ Clin Nucl Med - 1998. N 23. P. - 750-752.

43. McGuirt WF, Greven KM, Keyes JWJ, Williams DW, Watson NEJ, Geisinger KR, et al. Positron emission tomography in the evaluation of laryngeal carcinoma. ∕∕ Ann Otol Rhinol Laryngol - 1995 Vol. 104. P. - 274-278.

44.Schechter NR, Gillenwater AM, Byers RM, Garden AS, Morrison WH, Nguyen LN, et al. Can positron emission tomography improve the quality of care for head-and-neck cancer patients? ∕∕ Int J Radiat Oncol Biol Phys - 2001. N 51. P.-4-9.

45.In: Sobin LH, Wittekind Ch, editors. International Union Against Cancer. The TNM Classification of Malignant Tumours, 5^th ed. ∕∕ New York: Wiley. Liss - 1997.

46. Karim AB, Kralendonk JH, Njo KH, Tabak JM, Gort G. A critical look at the TNM classification for laryngeal carcinoma. ∕∕ Cancer - 1990. N - 65. P. - 1918-1922.

47. Lundgren J, Olofsson J. Multiple primary malignancies in patients treated for laryngeal carcinoma. H J Otolaryngol - 1986. N 15. P - 145-150.

48. Marks JE, Freeman RB, Lee F, Ogura JH. Carcinoma of the Supraglottic larynx. ∕∕ Am J Roentgenol - 1979. N 132. P. - 255-260.

49. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.

50. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. ∕∕ Clin Cancer Res - 2000. N 6. P. - 2718-2725.

5 LMyers EM. In: Myers EM, editor. Head and Neck Oncology: Diagnosis, Treatment and Rehabilitation. ∕∕ Boston, MA: Little, Brown and Co - 1991. P. -3-19.

52.Bataini JP, Bernier J, Brugere J, Jaulerry C, Picco C, Brunin F. Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. ∕∕ Radiother Oncol - 1985. N 3. P. - 245-255.

53.Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. ∕∕ Laryngoscope-2001. N 111. P. - 1079-1087.

54.Pradier R, Gonzalez A, Matos E, Loria D, Adan R, Saco P, et al. Prognostic factors in laryngeal carcinoma: experience in 296 male patients. ∕∕ Cancer - 1993. N 71. P.-2472-2476.

55.Stell PM. Prognosis in laryngeal carcinoma: host factors. ∕∕ Clin Otolaryngol - 1990. N 15. P. - 111-119.

56. Pera E, Moreno A, Galindo L. Prognostic factors in laryngeal carcinoma: a multifactorial study of 416 cases. H Cancer - 1986. N 58. P. - 928-934.

57. Lee WR, Mancuso AA, Saleh EM, Mendenhall WM, Parsons JT, Million RR. Can pretreatment computed tomography findings predict local control in T₃ squamous cell carcinoma of the glottis larynx treated with radiotherapy alone? ∕∕ Int J Radiat Oncol Biol Phys - 1993. N 25. P. - 683-687.

58. Fein DA, Mendenhall WM, Parsons JT, Million RR. T√T₃ squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate

analysis of variables potentially influencing local control. ∕∕ Int J Radiat Oncol Biol Phys - 1993. N 25. P. - 605-611.

59. Wang CC, Efird JT. Does prolonged treatment course adversely affect local control of carcinoma of the larynx? ∕∕ Int J Radiat Oncol Biol Phys - 1994. N 29. P. - 657-660.

60. Manni JJ, Terhaard CH, de Boer MF, Croll GA, Hilgers FJ, Annyas AA, et al. Prognostic factors for survival in patients with T₃ laryngeal carcinoma. ∕∕ Am J Surg - 1992. N 164. P. - 682-687.

61. Georgiou A, Gomatos IP, Ferekidis E, Syrigos K, Bistola V, Giotakis J, et al. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. ∕∕ Eur J Surg Oncol - 2001. N 27. P. - 574-580.

62. Yuen AP, Lam KY, Choy JT, Ho WK, Wei WL The Clinicopathological significance of bcl-2 expression in the surgical treatment of laryngeal carcinoma. ∕∕ Clin Otolaryngol - 2001. N 26. P. - 129-133.

63. Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, et al. Treatment results and prognostic factors of advanced T√T₄ laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. ∕∕ Int J Radiat Oncol Biol Phys - 2001. N 50. P. - 1172-1180.

64. Lutterbach J, Guttenberger R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. ∕∕ Int J Radiat Oncol Biol Phys - 2000. N 48. P. - 1345-1350.

65. Kamijo T, Yokose T, Hasebe T, Yonou H, Hayashi R, Ebihara S, et al. Image analysis of microvessel surface area predicts radiosensitivity in early-stage laryngeal carcinoma treated with radiotherapy. ∕∕ Clin Cancer Res - 2001. N 7. P.-2809-2814.

66. Groome PA, O’Sullivan B, Irish JC, Rothwell DM, Math KS, Bissett RJ, et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles? ∕∕ J Clin Epidemiol - 2001. N 54. P. - 301-315.

67. Veterans. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. ∕∕ N. Engl. J. Med. - 1991. N 324. P. - 1685-1690.

68. Forastiere AA, Berkey B, Maor M, Weber R, Geopfert H, Morrison WH, et al. Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone. Intergroup Trial R91-1L∕/Proc ASCO -2001. Vol. 20:2a.

69. Carding P, Welch A, Owen S, Stafford F. Surgical voice restoration. U Lancet -2001. N 357. P.-1463-1464.

70.Strong M. Laser management of premalignant lesions of the larynx. In: Alberti P, Bryce D, editors. Workshops from the Centennial Conference on Laryngeal Cancer. ∕∕ East Norwalk, CT: Appleton-Century-Crofts - 1976. Vol. 154.

7 LMcGuirt WF, Koufman JA. Endoscopic laser surgery: an alternative in laryngeal cancer treatment. ∕∕ Arch Otolaryngol Head Neck Surg - 1987. N

113. P.-501-505.

72. Harwood A. Cancer of the larynx*∕the Toronto experience. ∕∕ J Otolaryngol - 1982. N 11. P. - 1.

73. Elman AJ, Goodman M, Wang CC, Pilch B, Busse J. In situ carcinoma of the vocal cords. ∕∕ Cancer - 1979. N 43. P. - 2422-2428.

74. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. ∕∕ Int J Radiat Oncol Biol Phys -

2000. N48. P.-7-16.

75. Bron LP, Soldati D, Zouhair A, Ozsahin M, Brossard E, Monnier P, et al. Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or Cricohyoidoepiglottopexy versus radiotherapy. ∕∕ Head Neck - 2001. N 23. P. - 823-829.

76. Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis. ∕∕ Ann Otol Rhinol Laryngol - 2001. N 110. P. - 312-318.

77. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T√ T₂N₀ squamous cell carcinoma of the glottic larynx treated with radiation therapy. ∕∕ J Clin Oncol - 2001. N 19. P. - 4029-4036.

78.Olofsson J, Williams GT, Rider WD, Bryce DP. Anterior commissure carcinoma: primary treatment with radiotherapy in 57 patients. H Arch Otolaryngol - 1972. N 95. P. - 230-233.

79. Kirchner J, Fischer J. Anterior commissure cancer. In: Alberti P, Bryce D, editors. Workshops from the Centennial Conference on Laryngeal Cancer. ∕∕ East Norwalk, CT: Appleton-Century-Crofts - 1976. Vol. 679.

80. Leemans CR, Tiwari R, van dW I, Karim AB, Nauta JJ, Snow GB. The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts. ∕∕ Laryngoscope - 1990. N 100. P. - 1194- 1198.

SLPiquet JJ, Desaulty A, Decroix G. Crico-hyoido-epiglotto-pexy: surgical technic and functional results. ∕∕ Ann Otolaryngol Chir Cervicofac - 1974. N

91. P.-681-686.

82.LaccouiTeye H, Laccourreye O, Weinstein G, Menard M, Brasnu D. Supracricoid laryngectomy with Cricohyoidopexy: a partial laryngeal procedure for selected Supraglottic and transglottic carcinomas. ∕∕ Laryngoscope - 1990. N 100. P. - 735-741.

83.Schwaab G, Kolb F, Julieron M, Janot F, Le Ridant AM, Mamelle G, et al. Subtotal laryngectomy with Cricohyoidopexy as first treatment procedure for Supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974- 1997). H Eur Arch Otorhinolaryngol - 1991. N 162. P. - 246-249.

84. Piquet JJ, Chevalier D. Subtotal laryngectomy with Crico-Iiyoidoepiglotto- pexy for the treatment of extended glottic carcinomas. ∕∕ Am J Surg - 1991. N 162. P.-357-361.

85. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy’s Committee for Head and Neck Surgery and Oncology. ∕∕ Arch Otolaryngol HeadNeckSurg-1991. N 117. P.-601-605.

86. Wolf GT. Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy: intergroup trial R91-l 1. ∕∕ J Clin Oncol -

2001. N 19. P.-28-31.

87. Robbins KT, Atkinson JL, Byers RM, Cohen JI, Lavertu P, Pellitteri P. The use and misuse of neck dissection for head and neck cancer. ∕∕ J Am Coll Surg -2001. N 193. P.-91-102.

88. Chan AW, Ancukiewicz M, Carballo N, Montgomery W, Wang CC. The role of postradiotherapy neck dissection in Supraglottic carcinoma. ∕∕ Int J Radiat Oncol Biol Phys - 2001. N 50. P. - 367-375.

89. Leon X, Quer M, Orus C, Lopez M, Gras JR, Vega M. Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy. ∕∕ Head Neck - 2001. N 23. P. - 733-738.

90. Anderson WF, Hawk E, Berg CD. Secondary chemoprevention of upper aerodigestive tract tumors. ∕∕ Semin Oncol - 2001. N 28. P. - 106-120.

9LForastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, et al. Randomized comparison of cisplatin plus fluorouracil and Carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. ∕∕ J Clin Oncol - 1992. N 10. P. - 1245-1251.

92. Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. ∕∕ J Clin Oncol - 1992. N 10. P. - 257-263.

93. Clavel M, Vermorken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornagel JH, et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group. ∕∕ Ann Oncol - 1994. N 5. P. - 521-526.

94. Morton RP, Rugman F, Dorman EB, Stoney PJ, Wilson JA, McCormick M, et al. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. ∕∕ Cancer Chemother Pharmacol - 1985. N 15. P. - 283-289.

95. Adelstein DJ. The community approach to salvage therapy for advanced head and neck cancer. ∕∕ Semin Oncol - 1994. N 21. P. - 52-57.

96. Mazer TM, Robbins KT, McMurtrey MJ, Byers RM. Resection of pulmonary metastases from squamous carcinoma of the head and neck. ∕∕ Am J Surg - 1988. N 156. P.-238-242.

97. Muller R, Paneff J, Kollner V, Koch R. Quality of life of patients with laryngeal carcinoma: a post-treatment study. ∕∕ Eur Arch Otorhinolaryngol - 2001. N 258. P.-276-280.

98. Dorresteijn LD, Kappelle AC, Boogerd W, Klokman WJ, Balm AJ, Keus RB, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. ∕∕ J Clin Oncol - 2002. N 20. P. - 282-288.

99. Boysen M, Natvig K, Winther FO, Tausjo J. Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck. ∕∕ J Otolaryngol - 1985. N 14. P. - 211-214.

100. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. ∕∕ Eur J Cancer - 1992. N 28. P. - 426-430.

101. Grau JJ, Cuchi A, Traserra J, Firvida JL, Arias C, Blanch JL, et al. Follow-up study in head and neck cancer: cure rate according to tumor location and stage. ∕∕ Oncology - 1997. N 54. P. - 38-42.

102. Snow GB. Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long? ∕∕ Eur J Cancer - 1992. N 28. P. - 315-316.

103. Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. H J Clin Oncol - 2000. N 18. P. - 651-658.

104. Engelen AM, Stalpers LJ, Manni JJ, Ruijs JH, van Daal WA. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. ∕∕ Eur Arch Otorhinolaryngol - 1992. N 249. P. - 364-369.

105. Stalpers LJ, van Vierzen PB, Brouns JJ, Bruaset I, Manni JJ, Verbeek AL, et al. The role of yearly chest radiography in the early detection of lung cancer following oral cancer. ∕∕ Int J Oral Maxillofac Surg - 1989. N 18. P. - 99-103.

106. Чаклин A.В. Краевые особенности распространения злокачественных опухолей. - Jl., 1963. - 184 с.

107. Нугманов С.Н. Эпидемиология злокачественных опухолей в Казахстане. - Алма-Ата, 1969. - 280 с.

108. Чаклин А.В. Пути и методы изучения эпидемиологии злокачественных опухолей в СССР // Эпидемиология рака в СССР и США. - M., 1979. - С. 32-45.

109. Мерков А.М. Источники сведения о частоте рака, статистические показатели частоты рака и их изображение на географической карте // Методы изучения эпидемиологии злокачественных опухолей. -M.: Медицина, 1970. - С.17-23.

110. Мерабишвили В.M., Кисельникова И.В., Ковалева Н.С. Методологические аспекты оценки деятельности онкологической

службы (контроль достоверности учёта больных злокачественными новообразованиями). ∕∕ Bonp. онкол. - 1986. - Т. 32, № 12. - С. 3-7.

111. Мерков А.М. Демографическая статистика: Статистика населения. -M., 1965.-215 с.

112. Сепетлиев Д. Статистические методы в научных медицинских исследованиях. - M., 1968. - 420 с.

113. Doll R. Geographical distribution of cancer ∕∕ Brit. J. Cancer. - 1969. - Vol. 23, № 1.-P. 1-3.

114. Мерков A.M., Поляков Jl.E. Санитарная статистика. - Л.: Медицина, 1974. - 384 с.

115. Общая теория статистики / под ред. Боярского А.Я. - M., 1977. - 326 с.

116. Статистические методы и вычислительная техника в социально­гигиенических исследованиях. - M., 1977. - 279 с.

117. Гланц С. Медико-биологическая статистика / пер. с англ. - M.: Практика, 1998. - 459 с.

118. Применение методов статистического анализа для изучения общественного здоровья и здравоохранения. - M., 2004. - 180 с.

119. Игисинов С.И. Способ составления и применения картограмм в онкологической практике. // Здравоохр. Казахстана. - 1974. - № 2. - С. 69-71.

120. Двойрин В. В. Методы эпидемиологических исследований при злокачественных опухолях. // Медицина. - 1975. - С. 86-94.

121. Организация онкологической службы в России (методологические рекомендации, пособие для врачей). / под ред. Чиссова В.И., Старинского В.В., Ковалева Б.Н. - M., 2007. - С. 130-137.